Ventilatory management of acute lung injury and acute respiratory distress syndrome.
Abstract
CONTEXT
The acute lung injury and acute respiratory distress syndrome are critical illnesses associated with significant morbidity
and mortality. Mechanical ventilation is the cornerstone of supportive therapy. However, despite several important advances,
the optimal strategy for ventilation and adjunctive therapies for patients with acute lung injury and acute respiratory distress
syndrome is still evolving.
EVIDENCE ACQUISITION
To identify reports of invasive ventilatory and adjunctive therapies in adult patients with acute lung injury and acute respiratory
distress syndrome, we performed a systematic English-language literature search of MEDLINE (1966-2005) using the Medical Subject
Heading respiratory distress syndrome, adult, and related text words, with emphasis on randomized controlled trials and meta-analyses.
EMBASE and the Cochrane Central Register of Controlled Trials were similarly searched. The search yielded 1357 potential articles
of which 53 were relevant to the study objectives and considered in this review.
EVIDENCE SYNTHESIS
There is strong evidence to support the use of volume- and pressure-limited lung-protective ventilation in adult patients
with acute lung injury and acute respiratory distress syndrome. The benefit of increased levels of positive end-expiratory
pressure and recruitment maneuvers is uncertain and is being further evaluated in ongoing trials. Existing randomized controlled
trials of alternative ventilation modes, such as high-frequency oscillation and adjunctive therapies, including inhaled nitric
oxide and prone positioning demonstrate no significant survival advantage. However, they may have a role as rescue therapy
for patients with acute respiratory distress syndrome with refractory life-threatening hypoxemia.
CONCLUSIONS
Volume- and pressure-limited ventilation strategies should be used in managing adult acute lung injury and acute respiratory
distress syndrome patients. Further research is needed to identify barriers to widespread adoption of this strategy, as well
as the role of alternative ventilation modes and adjunctive therapies.
Links
Authors
Institution
Interdepartmental Division of Critical Care Medicine and Department of Medicine, University of Toronto and University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada.
Source
JAMA : the journal of the American Medical Association 294:22 2005 Dec 14 pg 2889-96MeSH
HumansRespiration, Artificial
Respiratory Distress Syndrome, Adult
Pub Type(s)
Journal ArticleResearch Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
16352797
Log In

